- Home
- ARVN vs CSGS Comparison
ARVN vs CSGS Comparison
Compare ARVN & CSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- CSGS
- Stock Information
- Founded
- ARVN 2015
- CSGS 1994
- Country
- ARVN United States
- CSGS United States
- Employees
- ARVN N/A
- CSGS N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- CSGS EDP Services
- Sector
- ARVN Health Care
- CSGS Technology
- Exchange
- ARVN Nasdaq
- CSGS Nasdaq
- Market Cap
- ARVN 1.4B
- CSGS 1.5B
- IPO Year
- ARVN 2018
- CSGS 1996
- Fundamental
- Price
- ARVN $17.77
- CSGS $64.01
- Analyst Decision
- ARVN Strong Buy
- CSGS Buy
- Analyst Count
- ARVN 12
- CSGS 7
- Target Price
- ARVN $58.82
- CSGS $69.29
- AVG Volume (30 Days)
- ARVN 1.1M
- CSGS 345.7K
- Earning Date
- ARVN 02-11-2025
- CSGS 02-05-2025
- Dividend Yield
- ARVN N/A
- CSGS 2.00%
- EPS Growth
- ARVN N/A
- CSGS 37.73
- EPS
- ARVN N/A
- CSGS 3.03
- Revenue
- ARVN $263,399,999.00
- CSGS $1,197,248,000.00
- Revenue This Year
- ARVN N/A
- CSGS $4.16
- Revenue Next Year
- ARVN $1.63
- CSGS $3.37
- P/E Ratio
- ARVN N/A
- CSGS $21.13
- Revenue Growth
- ARVN 235.54
- CSGS 2.39
- 52 Week Low
- ARVN $16.61
- CSGS $39.56
- 52 Week High
- ARVN $51.51
- CSGS $65.53
- Technical
- Relative Strength Index (RSI)
- ARVN 44.33
- CSGS 69.76
- Support Level
- ARVN $17.19
- CSGS $63.06
- Resistance Level
- ARVN $20.38
- CSGS $65.53
- Average True Range (ATR)
- ARVN 1.38
- CSGS 1.57
- MACD
- ARVN 0.08
- CSGS -0.02
- Stochastic Oscillator
- ARVN 30.77
- CSGS 80.95
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About CSGS CSG Systems International Inc.
CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).